Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Andreas Janzer"'
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Systematic analysis of the control of dynamic cellular processes remains a challenge. Here the authors introduce a pipeline enabling them to identify TFs involved in Src-induced cellular transformation, and find that a large number of TFs with divers
Externí odkaz:
https://doaj.org/article/290b03e8292f4574bc8968e5aeb70019
Autor:
Januka Khanal, Daniel P. Cahill, Joseph Buehler, Diana D. Shi, Yu-Fen Lin, Misty S. Martin-Sandoval, Michael M Levitt, Keith L. Ligon, Harley I. Kornblum, Adam C. Wang, Sungwoo Lee, Dennis M. Bonal, John M. Asara, Mark A. Lehrman, Isaac S. Harris, Andreas Janzer, Cylaina E. Bird, Michael Jeffers, Ralph J. DeBerardinis, William G. Kaelin, Tammie Dang, Nathalie Y. R. Agar, Sylwia A. Stopka, Lauren C. Gattie, Stefan Gradl, Lauren G. Zacharias, Michael S. Regan, Quang-Dé Nguyen, Tak W. Mak, Sabina Signoretti, Kalil G. Abdullah, Peter Ly, Andreas Sutter, Timothy E. Richardson, Samuel K. McBrayer, Thomas P. Mathews, Milan R. Savani, Jennifer E. Endress, Min Xu, Wenhua Gao, Bofu Huang, Rebecca B. Jennings, Ryan E. Looper
SUMMARYMutations affecting isocitrate dehydrogenase (IDH) enzymes are prevalent in glioma, leukemia, and other cancers. Although mutant IDH inhibitors are effective against leukemia, they appear less active in aggressive glioma, underscoring the need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef99b65b0828b3d636a1f8cfa0b31ac5
https://doi.org/10.1101/2021.11.30.470443
https://doi.org/10.1101/2021.11.30.470443
Autor:
Diana D. Shi, Milan R. Savani, Michael M. Levitt, Adam C. Wang, Jennifer E. Endress, Cylaina E. Bird, Joseph Buehler, Sylwia A. Stopka, Michael S. Regan, Yu-Fen Lin, Vinesh T. Puliyappadamba, Wenhua Gao, Januka Khanal, Laura Evans, Joyce H. Lee, Lei Guo, Yi Xiao, Min Xu, Bofu Huang, Rebecca B. Jennings, Dennis M. Bonal, Misty S. Martin-Sandoval, Tammie Dang, Lauren C. Gattie, Amy B. Cameron, Sungwoo Lee, John M. Asara, Harley I. Kornblum, Tak W. Mak, Ryan E. Looper, Quang-De Nguyen, Sabina Signoretti, Stefan Gradl, Andreas Sutter, Michael Jeffers, Andreas Janzer, Mark A. Lehrman, Lauren G. Zacharias, Thomas P. Mathews, Julie-Aurore Losman, Timothy E. Richardson, Daniel P. Cahill, Ralph J. DeBerardinis, Keith L. Ligon, Lin Xu, Peter Ly, Nathalie Y.R. Agar, Kalil G. Abdullah, Isaac S. Harris, William G. Kaelin, Samuel K. McBrayer
Publikováno v:
Cancer Cell. 40:939-956.e16
Mutations affecting isocitrate dehydrogenase (IDH) enzymes are prevalent in glioma, leukemia, and other cancers. Although mutant IDH inhibitors are effective against leukemia, they seem to be less active in aggressive glioma, underscoring the need fo
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Nature Communications
Nature
Nature Communications
Nature
Transient activation of Src oncoprotein in non-transformed, breast epithelial cells can initiate an epigenetic switch to the stably transformed state via a positive feedback loop that involves the inflammatory transcription factors STAT3 and NF-κB.
Autor:
Andreas Sutter, Harley I. Kornblum, Jennifer E. Endress, Isaac S. Harris, William G. Kaelin, Adam C. Wang, Daniel P. Cahill, Min Xu, Diana D. Shi, Januka Khanal, Wenhua Gao, Stefan Gradl, Dennis M. Bonal, Quang-Dé Nguyen, Keith L. Ligon, Samuel K. McBrayer, Michael Jeffers, Michael M Levitt, Andreas Janzer, Kalil G. Abdullah
Publikováno v:
Neuro-oncology Advances
70–90% of lower-grade gliomas and secondary glioblastomas harbor gain-of-function mutations in isocitrate dehydrogenase 1 (IDH1), causing overproduction of the oncometabolite (R)-2-hydroxyglutarate [(R)-2HG]. Although inhibitors of mutant IDH enzym
Autor:
Ricarda Schlenz, Stefan Kaulfuss, Renan Borowicz, Andreas Janzer, Andrea Triller, Gerhard Siemeister, Sven Christian, Katrin Gutberlet, Ashley Eheim, Katrin Jaensch, Michael Jeffers
Publikováno v:
Cancer Research. 81:2077-2077
Introduction: BAY2402234 is a potent and specific orally administered inhibitor of dihydroorotate dehydrogenase (DHODH) which showed anti-tumor activity in preclinical models of AML and is under clinical evaluation in myeloid malignancies (NCT0340472
Autor:
Claudia Merz, Marcus Bauser, Martin Michels, Ashley Eheim, David T. Scadden, Henrik Seidel, Ralf Lesche, Timo Stellfeld, Hanna Meyer, Pascale Lejeune, Thomas Mueller, Detlef Stoeckigt, David B. Sykes, Steven James Ferrara, Sven Christian, Andrea Haegebarth, Judith Guenther, Andreas Janzer, Katja Zimmermann, Sherif El Sheikh, Stefan Gradl, Michael Bruening
Publikováno v:
Cancer Research. 78:DDT02-04
Acute myeloid leukemia (AML), the most common acute leukemia in adults, is an aggressive hematologic malignancy resulting in bone marrow failure with a poor outcome; overall survival is approximately 25% at five years. Treatment options, in particula
Autor:
Roland Schüle, Magdalena Rohde, Andreas Janzer, Jutta Kirfel, Dominica Willmann, Hubert Schorle, Angela Egert, Elisabeth Sievers
Publikováno v:
Experimental Cell Research. 348:123-131
Cell migration is a central process in the development and maintenance of multicellular organisms. Tissue formation during embryonic development, wound healing, immune responses and invasive tumors all require the orchestrated movement of cells to sp
Autor:
Anders Friberg, Claudia Merz, Stefan Gradl, Marcus Bauser, David T. Scadden, Ashley Eheim, Henrik Seidel, Andrea Haegebarth, Hanna Meyer, Steven James Ferrara, Krzysztof Brzezinka, Pascale Lejeune, David B. Sykes, Julie-Aurore Losman, Katja Zimmermann, Laura Evans, Sven Christian, Detlef Stoeckigt, Andreas Janzer, Ralf Lesche
Publikováno v:
Leukemia. 33(10)
Acute myeloid leukemia (AML) is a devastating disease, with the majority of patients dying within a year of diagnosis. For patients with relapsed/refractory AML, the prognosis is particularly poor with currently available treatments. Although genetic
Autor:
Benjamin Izar, Levi A. Garraway, Andreas Janzer, Kevin Struhl, John G. Doench, Asaf Rotem, Zhe Ji
Publikováno v:
Proceedings of the National Academy of Sciences. 112:5708-5713
Colony formation in soft agar is the gold-standard assay for cellular transformation in vitro, but it is unsuited for high-throughput screening. Here, we describe an assay for cellular transformation that involves growth in low attachment (GILA) cond